Galatea Surgical In-Date
Galatea Surgical / Tepha, a subsidiary of BD, develops advanced scaffold technology for soft tissue support in plastic and reconstructive surgery. Its platform is built on the Galatea Scaffold, a bioresorbable monofilament mesh made from P4HB (poly-4-hydroxybutyrate), originally developed by Tepha. The scaffold provides durable support during the critical healing phase and gradually resorbs, leaving no permanent material behind. Commonly used in breast and abdominal wall procedures, Galatea’s solutions are designed to integrate naturally with the body, offering strength, flexibility, and optimal aesthetic outcomes without compromising long-term biocompatibility.